We read with interest the paper by Papanicolas and colleagues titled *'Bacterial viability in faecal transplants: Which bacteria survive?*' \[[@bb0005]\]. The authors demonstrate a reduction in gut anaerobes following production of FMT in ambient air compared to anaerobic conditions. They conclude that adherence to strict anaerobic stool processing protocols is likely to increase efficacy for FMT. These findings, albeit interesting, have significant limitations and should be interpreted with caution.

Several facultative anaerobes in the gut employ resilient aero-tolerant spores to survive externally for prolonged periods of time and facilitate transmission into a new host \[[@bb0010]\]. They germinate only once in an anaerobic niche such as a host colon and thereby are likely to survive production of FMT in ambient air \[[@bb0015]\]. Spores cannot be detected by the standard DNA extraction techniques used by the authors and required extended anaerobic culture based approaches \[[@bb0020]\]. Encapsulated spores from Clostridiales group of organisms have been shown to induce remission in ulcerative colitis in early phase clinical trials \[[@bb0025]\].

It maybe simplistic to make a qualitative assessment of a therapeutic product as complex as FMT based on the experimental design adopted by the authors. We are increasingly recognising the role of oxygen independent non-bacterial constituents including bacteriophages, metabolites and bile acids in FMT. Importantly, there is no evidence to suggest ambient air processing of FMT changes clinical outcomes. A more focused approach through robust basic science studies that include animal models and anaerobic culturing is now essential to understand the effects of technical variations in FMT production.
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